SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Juhi Misra, Sindhu T. Mohanty, Sanjeev Madan, James A. Fernandes, F. Hal Ebetino, R. Graham G. Russell, Ilaria Bellantuono, Zoledronate Attenuates Accumulation of DNA Damage in Mesenchymal Stem Cells and Protects Their Function, STEM CELLS, 2016, 34, 3
  2. 2
    Alessandro Sciarra, Stefano Salciccia, A Novel Therapeutic Option for Castration-resistant Prostate Cancer: After or Before Chemotherapy?, European Urology, 2014, 65, 5, 905

    CrossRef

  3. 3
    Margarete K. Akens, Lisa Wise-Milestone, Emily Won, Joerg Schwock, Albert J.M. Yee, Brian C. Wilson, Cari M. Whyne, In vitro and in vivo effects of photodynamic therapy on metastatic breast cancer cells pre-treated with zoledronic acid, Photodiagnosis and Photodynamic Therapy, 2014, 11, 3, 426

    CrossRef

  4. 4
    Subhajit Das, Peter A. Edwards, Julie C. Crockett, Michael J. Rogers, Upregulation of endogenous farnesyl diphosphate synthase overcomes the inhibitory effect of bisphosphonate on protein prenylation in Hela cells, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014, 1841, 4, 569

    CrossRef

  5. 5
    Yi-Chia Lin, Po-Cheng Liao, Te-Fu Tsai, Kuang-Yu Chou, Hung-En Chen, Ji-Fan Lin, Thomas I-Sheng Hwang, Zoledronic Acid Elicits Proinflammatory Cytokine Profile in Osteolytic Prostate Cancer Cells, ISRN Pathology, 2014, 2014, 1

    CrossRef

  6. 6
    Xiaoqiang Tang, Chunfen Mo, Yongsheng Wang, Dandan Wei, Hengyi Xiao, Anti-tumour strategies aiming to target tumour-associated macrophages, Immunology, 2013, 138, 2
  7. 7
    Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, Claude El Kouri, Laurent Bastit, Meryem Ktiouet, Khemaies Slimane, Xavier Murraciole, Stéphane Guérif, Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient–nurse satisfaction, Supportive Care in Cancer, 2013, 21, 6, 1613

    CrossRef

  8. 8
    Eric R. Carlson, Kenneth E. Fleisher, Salvatore L. Ruggiero, Metastatic Cancer Identified in Osteonecrosis Specimens of the Jaws in Patients Receiving Intravenous Bisphosphonate Medications, Journal of Oral and Maxillofacial Surgery, 2013, 71, 12, 2077

    CrossRef

  9. 9
    Hiroji Uemura, Masahiro Yanagisawa, Ichirou Ikeda, Kiyoshi Fujinami, Akira Iwasaki, Sumio Noguchi, Kazumi Noguchi, Yoshinobu Kubota, Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial, International Journal of Clinical Oncology, 2013, 18, 3, 472

    CrossRef

  10. 10
    Roheena Z Panni, David C Linehan, David G DeNardo, Targeting tumor-infiltrating macrophages to combat cancer, Immunotherapy, 2013, 5, 10, 1075

    CrossRef

  11. 11
    Dolores Isla, Ruth Afonso, Joaquim Bosch-Barrera, Natividad Martínez, Zoledronic acid in lung cancer with bone metastases: a review, Expert Review of Anticancer Therapy, 2013, 13, 4, 421

    CrossRef

  12. 12
    Maria A. Lopez-Olivo, Nimit A. Shah, Greg Pratt, Jan M. Risser, Elaine Symanski, Maria E. Suarez-Almazor, Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis, Supportive Care in Cancer, 2012, 20, 11, 2985

    CrossRef

  13. 13
    J.-J. Body, P. Bergmann, S. Boonen, J.-P. Devogelaer, E. Gielen, S. Goemaere, J.-M. Kaufman, S. Rozenberg, J.-Y. Reginster, Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications, Osteoporosis International, 2012, 23, S1, 1

    CrossRef

  14. 14
    Tim Kees, Mikala Egeblad, Innate Immune Cells in Breast Cancer – From Villains to Heroes?, Journal of Mammary Gland Biology and Neoplasia, 2011, 16, 3, 189

    CrossRef

  15. 15
    Rakesh K. Goyal, G. Singh, A. K. Madan, Models for anti-tumor activity of bisphosphonates using refined topochemical descriptors, Naturwissenschaften, 2011, 98, 10, 871

    CrossRef